Merit Medical Systems, Inc.MMSINASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 83% recommend buying.

Consensus Rating

Buy

12 analysts·Moderate coverage

83%

Rating Distribution

Strong Buy

00%

Buy

1083%

Hold

18%

Sell

18%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 27% higher.

Bear Case

$99.00

+20%

Consensus

$104.33

+27%

Bull Case

$108.00

+31%

Price Range12 analysts

Low

Consensus

High

$99.00

$108.00

Current Target

Current Price

$82.31

Upside to Target

$22.02

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Unable to load analyst estimates

Earnings Surprises

Earnings surprise history unavailable.

Recent Analyst Actions

Dec 17, 2025Canaccord Genuity

Merit Medical price target raised to $99 from $93 at Canaccord

Target:$99.00

+14.0%from $86.85

Dec 16, 2025Robert W. Baird

Merit Medical price target raised to $108 from $103 at Baird

Target:$108.00

+25.0%from $86.41

Oct 31, 2025Barrington

Merit Medical price target raised to $106 from $103 at Barrington

Target:$106.00

+19.1%from $88.98

Oct 31, 2025Robert W. Baird

Merit Medical price target raised to $103 from $102 at Baird

Target:$103.00

+19.6%from $86.16

Oct 16, 2025Canaccord Genuity

Merit Medical price target raised to $104 from $103 at Canaccord

Target:$104.00

+29.2%from $80.47

May 21, 2025Canaccord Genuity

Merit Medical price target raised to $112 from $108 at Canaccord

Target:$112.00

+16.1%from $96.49

Apr 25, 2025Barrington

Merit Medical price target lowered to $103 from $111 at Barrington

Target:$103.00

+9.7%from $93.86

Apr 25, 2025Robert W. Baird

Merit Medical price target lowered to $110 from $111 at Baird

Target:$110.00

+16.3%from $94.61

Apr 25, 2025Wells Fargo

Merit Medical price target lowered to $106 from $117 at Wells Fargo

Target:$106.00

+12.0%from $94.61

Oct 15, 2024Robert W. Baird

Merit Medical Systems, Inc. (MMSI) PT Raised to $107 at Baird

Target:$107.00

+12.0%from $95.52

Sep 16, 2024Needham

Needham Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)

Target:$105.00

+9.2%from $96.16

Sep 16, 2024Wells Fargo

Merit Medical Systems, Inc. (MMSI) PT Raised to $103 at Wells Fargo

Target:$103.00

+7.1%from $96.16

Sep 16, 2024Bank of America Securities

Merit Medical Systems, Inc. (MMSI) PT Raised to $103 at BofA Securities

Target:$103.00

+7.1%from $96.16

Sep 9, 2024Piper Sandler

Merit Medical price target raised to $110 from $100 at Piper Sandler

Target:$110.00

+13.9%from $96.58

Aug 5, 2024Bank of America Securities

Merit Medical Systems, Inc. (MMSI) PT Raised to $92 at BofA Securities

Target:$92.00

+5.2%from $87.44

Aug 2, 2024Piper Sandler

Merit Medical price target raised to $100 from $97 at Piper Sandler

Target:$100.00

+15.1%from $86.86

Jul 2, 2024Canaccord Genuity

Merit Medical price target raised to $125 from $102 at Canaccord

Target:$125.00

+46.0%from $85.64

Jun 13, 2024Wells Fargo

Wells Fargo Reiterates Equal Weight Rating on Merit Medical Systems, Inc. (MMSI)

Target:$85.00

+2.1%from $83.25

May 1, 2024Piper Sandler

Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at Piper Sandler

Target:$97.00

+25.8%from $77.12

Apr 11, 2024C.L. King

Merit Medical initiated with a Buy at CL King

Target:$88.00

+22.3%from $71.95

Oct 27, 2023Needham

Merit Medical Systems Had A Solid Q3, But This Analyst Has Lowered The Price Target On The Stock

Target:$81.00

+17.7%from $68.83

Jul 6, 2023Barrington

Merit Medical's Recent M&A Efforts Set To Show Early Impact In FY24: Analyst Insight

Target:$95.00

+19.7%from $79.35

Jun 9, 2023Needham

Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement

Target:$96.00

+14.5%from $83.81

Apr 27, 2023Needham

Merit Medical To See Sustained Revenue Growth Despite Macro Headwinds, Bullish Analyst Says

Target:$90.00

+10.1%from $81.76

Sep 2, 2022Canaccord Genuity

Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $69

Target:$69.00

+20.2%from $57.39

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance